{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T10:55:14Z","timestamp":1774608914847,"version":"3.50.1"},"reference-count":25,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Rh-GIOP is supported by a joint funding from Amgen, Biogen, BMS, Chugai, Generic Assays, GSK, Hexal, Horizon Therapeutics, Lilly, Medac, Mundipharma, Novartis, Pfizer, Roche and Sanofi.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Background: Glucocorticoids (GCs) can cause osteoporosis (OP). Prior observational research on bone density and the effects of GCs in polymyalgia rheumatica (PMR) and vasculitides is scarce and inconclusive. Methods: Rh-GIOP is a prospective cohort study of bone health in patients with inflammatory rheumatic diseases. In this cross-sectional baseline analysis, we focused on patients with PMR and different forms of vasculitides. Multivariable linear regression was used to model the effect of current and cumulative GC intake on the minimum T-score at any site (mTs; at either lumbar spine or hip), with comprehensive adjustment for confounders. In separate models, GCs were modelled both as continuous and categorical predictors. Sensitivity analyses, stratifying by measurement site and disease, were conducted. Results: A total of 198 patients, with a mean age of 67.7 \u00b1 11.4 years and a mean disease duration of 5.3 \u00b1 6.3 years, were included. Most patients suffered from PMR (36%), giant cell arteritis (26%) or granulomatosis with polyangiitis (17%). Women comprised 66.7% of the patients, and 87.4% were currently taking GCs. The mean CRP was 13.2 \u00b1 26.1 mg\/L. OP diagnosed by dual energy X-ray absorptiometry (DXA) (T-score \u2264 \u22122.5) was present in 19.7% of the patients. While 88% were taking vitamin D supplements, calcium supplementation (4%) and treatment with anti-resorptive agents (17%) were relatively infrequent. Only 7% had a vitamin D deficit. Neither current (\u03b2(continuous model) = \u22120.01, 97.5% CI \u20130.02 to 0.01; p(all models) \u2265 0.49) nor cumulative (\u03b2(continuous model) = 0.01, 97.5% CI \u22120.04 to 0.07; p(all models) \u2265 0.35) GC doses were associated with mTs in any model. CRP was not associated with mTs in any model (p(all models) \u2265 0.56), and no interaction between CRP and GC intake was observed (p for interaction(all models) \u2265 0.32). Across all analyses, lower body mass index (p(all models) \u2264 0.01), history of vertebral fractures (p(all models) \u2264 0.02) and proton-pump inhibitor intake (p(all models) \u2264 0.04) were associated with bone loss. Sensitivity analyses with femoral neck and lumbar spine T-scores as dependent variables led to similar results as the analysis that excluded patients with PMR. Conclusions: In this cohort of PMR and vasculitides, we found a similar prevalence of OP by DXA to the overall elderly German population. Vitamin D supplementation was very common, and vitamin D insufficiency was less frequent than expected in Germans. There was no association between current or cumulative GC intake, CRP and impaired bone density. Proton-pump inhibitors seem to be a major, but somewhat neglected, risk factor for OP and should be given more attention. Our findings require confirmation from longitudinal analyses of the Rh-GIOP and other cohorts.<\/jats:p>","DOI":"10.3390\/cells11030536","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:35:17Z","timestamp":1643974517000},"page":"536","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides\u2014Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3456-0597","authenticated-orcid":false,"given":"Andriko","family":"Palmowski","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Wiebe","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4104-5080","authenticated-orcid":false,"given":"Burkhard","family":"Muche","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Hermann","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-0668","authenticated-orcid":false,"given":"Christian","family":"Dejaco","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Medical University Graz, 8036 Graz, Austria"},{"name":"Rheumatology Service, South Tyrol Health Trust, 39031 Bruneck, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Matteson","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine and Health Sciences Research, Division of Rheumatology and Division of Epidemiology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2534-550X","authenticated-orcid":false,"given":"Frank","family":"Buttgereit","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41584-020-0370-z","article-title":"Views on glucocorticoid therapy in rheumatology: The age of convergence","volume":"16","author":"Buttgereit","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Paskins, Z., Whittle, R., Sultan, A.A., Muller, S., Blagojevic-Bucknall, M., Helliwell, T., Hider, S., Roddy, E., and Mallen, C. (2018). Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: A population-based study. BMC Med., 16.","DOI":"10.1186\/s12916-017-0987-1"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jbspin.2014.10.001","article-title":"2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"81","author":"Briot","year":"2014","journal-title":"Jt. Bone Spine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: A European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ncprheum0898","article-title":"Genomic and nongenomic effects of glucocorticoids","volume":"4","author":"Stahn","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"ref_8","unstructured":"(2021, December 29). e.V. DdDWOG. Leitlinie: Prophylaxe, Diagnostik und Therapie der Osteoporose. Available online: https:\/\/dv-osteologie.org\/uploads\/Leitlinie%202017\/Finale%20Version%20Leitlinie%20Osteoporose%202017_end.pdf."},{"key":"ref_9","unstructured":"World Health Organization (1994). Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Report of a WHO Study Group, WHO."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/annrheumdis-2014-206186","article-title":"Statistical review: Frequently given comments","volume":"74","author":"Lydersen","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00401706.1983.10487848","article-title":"Percentage Points for a Generalized ESD Many-Outlier Procedure","volume":"25","author":"Rosner","year":"1983","journal-title":"Technometrics"},{"key":"ref_12","first-page":"1","article-title":"Mice: Multivariate Imputation by Chained Equations in R","volume":"45","year":"2011","journal-title":"J. Stat. Softw."},{"key":"ref_13","unstructured":"Rabenberg, M., and Mensink, G. (2016). Vitamin-D-Status in Deutschland, Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung."},{"key":"ref_14","unstructured":"Fuchs, J., Scheidt-Nave, C., and Kuhnert, R. (2017). 12-Monats-Pr\u00e4valenz von Osteoporose in Deutschland, Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung."},{"key":"ref_15","first-page":"52","article-title":"Epidemiologie der Osteoporose\u2014Bone Evaluation Study","volume":"110","author":"Hadji","year":"2013","journal-title":"Dtsch Arztebl Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e000313","DOI":"10.1136\/rmdopen-2016-000313","article-title":"One-year effects of glucocorticoids on bone density: A meta-analysis in cohorts on high and low-dose therapy","volume":"2","author":"Lems","year":"2016","journal-title":"RMD Open"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6489631","DOI":"10.1155\/2021\/6489631","article-title":"Assessment of Low Bone Mineral Density in Untreated Patients with Takayasu\u2019s Arteritis","volume":"2021","author":"Mo","year":"2021","journal-title":"Biomed Res. Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/acr.22429","article-title":"Incidence of giant cell arteritis and characteristics of patients: Data-driven analysis of comorbidities","volume":"67","author":"Petri","year":"2015","journal-title":"Arthritis Care Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/annrheumdis-2016-eular.2880","article-title":"AB0575\u2005Steroid Use Is Protective of Osteoporosis in Polymyalgia Rheumatica Patients: A Case-Control Study","volume":"75","author":"Ling","year":"2016","journal-title":"Ann. Rheum. Dis"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/art.1780401115","article-title":"Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica","volume":"40","author":"Dolan","year":"1997","journal-title":"Arthritis Rheum."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/030097400750002030","article-title":"GMHDBMJTG. No permanent reduction in bone mineral density during treatment of polymyalgia rheumatica and temporal arteritis using low dose corticosteroids: A cross sectional study","volume":"29","author":"Haugeberg","year":"2000","journal-title":"Scand. J. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s198-002-8341-z","article-title":"Prevalence of reduced bone mineral density in patients with anti-neutrophil cytoplasmic antibody associated vasculitis and the role of immunosuppressive therapy: A cross-sectional study","volume":"13","author":"Boomsma","year":"2002","journal-title":"Osteoporos Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/archinte.166.22.2495","article-title":"High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study","volume":"166","author":"Schett","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/rheumatology\/keaa594","article-title":"Comparison of fracture risk between proton pump inhibitors and histamine-2 receptor antagonists in ANCA-associated vasculitis patients: A nested case\u2013control study","volume":"60","author":"Miyano","year":"2020","journal-title":"Rheumatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Glucocorticoid-Induced Bone Disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N. Engl. J. Med."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/3\/536\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:13:52Z","timestamp":1760134432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/3\/536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cells11030536"],"URL":"https:\/\/doi.org\/10.3390\/cells11030536","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]}}}